ArcherDX
Latest round
- Series C
Last raised
- Dec 2019
Total raised
- $153M
Investors
- 10
About ArcherDX
Founded in 2013 and based in Colorado, US, ArcherDX, Inc. develops cancer research kits and an accompanying software platform to help identify mutation points and genetic fusions. for USD 325 million. ArcherDX, Inc.4 billion. The company's products include FusionPlex, VariantPlex, and Immunoverse.
Who invested in ArcherDX
10 investors across 3 rounds
See all investors in ArcherDX
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about ArcherDX
Who invested in ArcherDX?
ArcherDX has 10 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has ArcherDX raised?
ArcherDX has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did ArcherDX last raise money?
ArcherDX's most recent round on record is a Series C, in Dec 2019.
What does ArcherDX do?
Founded in 2013 and based in Colorado, US, ArcherDX, Inc.
Where is ArcherDX headquartered?
ArcherDX is headquartered in Boulder, US.
Which VCs invest in companies like ArcherDX?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at ArcherDX's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like ArcherDX? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.